Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-01-26 @ 5:44 AM
Study NCT ID:
NCT02509494
Status:
COMPLETED
Last Update Posted:
2022-07-18
First Post:
2015-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo
Sponsor:
Janssen Vaccines & Prevention B.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-03
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-24
First Submit QC Date:
None
Study First Post Date:
2015-07-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-06-22
Results First Submit QC Date:
None
Results First Post Date:
2022-07-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-06-29
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-06-22
Last Update Post Date:
2022-07-18
Last Update Post Date Type:
ACTUAL